These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1396280)
1. Surfactant in the perinatal period. Jobe AH Early Hum Dev; 1992; 29(1-3):57-62. PubMed ID: 1396280 [TBL] [Abstract][Full Text] [Related]
2. Lung maturational agents and surfactant treatments: are they complementary in preterm infants? Jobe AH J Perinatol; 1989 Mar; 9(1):14-8. PubMed ID: 2709148 [TBL] [Abstract][Full Text] [Related]
3. Lung maturation: the survival miracle of very low birth weight infants. Jobe AH Pediatr Neonatol; 2010 Feb; 51(1):7-13. PubMed ID: 20225532 [TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of respiratory failure in the preterm infant. Jobe AH Ann Med; 1991 Dec; 23(6):687-91. PubMed ID: 1777225 [TBL] [Abstract][Full Text] [Related]
7. Surfactant in the preterm infant: what's going on. Dani C; Barp J; Berti E; Bertini G J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357 [TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of fetal lung immaturity. Cosmi EV; Di Renzo GC Fetal Ther; 1989; 4 Suppl 1():52-62. PubMed ID: 2577304 [TBL] [Abstract][Full Text] [Related]
9. [Surfactant synthesis and lung maturity]. Nagel H; During R Zentralbl Gynakol; 1985; 107(20):1219-25. PubMed ID: 3840943 [TBL] [Abstract][Full Text] [Related]
10. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599 [TBL] [Abstract][Full Text] [Related]
11. Corticosteroids and surfactant for prevention of neonatal RDS. Robertson B Ann Med; 1993 Jun; 25(3):285-8. PubMed ID: 8333929 [TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Jobe AH; Mitchell BR; Gunkel JH Am J Obstet Gynecol; 1993 Feb; 168(2):508-13. PubMed ID: 8438919 [TBL] [Abstract][Full Text] [Related]
13. Background to neonatal respiratory distress syndrome and treatment with exogenous surfactant. Robertson B Dev Pharmacol Ther; 1989; 13(2-4):159-63. PubMed ID: 2692998 [TBL] [Abstract][Full Text] [Related]
14. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology. Jobe A Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946 [TBL] [Abstract][Full Text] [Related]
16. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll RF; Wiswell T Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826 [TBL] [Abstract][Full Text] [Related]
18. Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: difference of in vitro and in vivo activities. Obladen M; Kampmann W; Zimmermann I; Lachmann B Eur J Pediatr; 1985 Jul; 144(2):195-9. PubMed ID: 3850023 [TBL] [Abstract][Full Text] [Related]
19. Effects of intrauterine infection or inflammation on fetal lung development. Westover AJ; Moss TJ Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):824-30. PubMed ID: 22816773 [TBL] [Abstract][Full Text] [Related]
20. The biochemistry of fetal lung development. Kresch MJ; Gross I Clin Perinatol; 1987 Sep; 14(3):481-507. PubMed ID: 3311536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]